Microbial transformation of ginsenoside-Rg 1 by Absidia coerulea and the reversal activity of the metabolites towards multi-drug resistant tumor cells

Fitoterapia

Volumn 82, Issue 8, 2011, Pages 1313-1317

  Liu, Xin ^a   Qiao, Lirui ^a   Xie, Dan ^a   Zhang, Yi ^a   Zou, Jianhua ^a   Chen, Xiaoguang ^a   Dai, Jungui ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Absidia coerulea AS 3.2462; Dehydrogenation; Ginsenoside Rg 1; Hydroxylation; Microbial transformation; Tumor MDR reversal activity

Indexed keywords

3 OXO 7 BETA HYDROXY PROTOPANAXATRIOL; 3 OXO 7 BETA,15 ALPHA DIHYDROXY PROTOPANAXATRIOL; 3 OXO PROTOPANAXATRIOL; 6 ALPHA,12 BETA DIHYDROXYDAMMAR 3 ONE O BETA DEXTRO GLUCOPYRANOSIDE; GINSENOSIDE F 1; GINSENOSIDE RG 1; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ABSIDIA; ABSIDIA COERULEA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM TRANSFORMATION; CHEMICAL STRUCTURE; DEGLYCOSYLATION; DEHYDROGENATION; DRUG HYDROXYLATION; FUNGAL STRAIN; HUMAN; HUMAN CELL; IN VITRO STUDY; METABOLITE; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TUMOR CELL;

ABSIDIA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOTRANSFORMATION; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GINSENOSIDES; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; PANAX; PHYTOTHERAPY; PLANT EXTRACTS;

ABSIDIA COERULEA; FUNGI;

EID: 80054914955     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2011.09.001     Document Type: Article

References (18)

1. P. Mistry, A.J. Stewart, W. Dangerfield, S. Okiji, C. Liddle, and D. Bootle In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576 Cancer Res 61 2001 749 758 (Pubitemid 32128642)
2. M. Raderer, and W. Scheithauer Clinical trials of agents that reverse multidrug resistance Cancer 72 1993 3553 3563 (Pubitemid 24000587)
3. 1 and protopanaxatriol J Pharmacol Sci 109 2009 504 510
4. D.G. Popovich, and D.D. Kitts Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line Arch Biochem Biophys 406 2002 1 8 (Pubitemid 35191710)
5. H.X. Sun, Z.G. Yang, and Y.P. Ye Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng Int Immunopharmacol 6 2006 14 25
6. Y. Zhao, L. Bu, H. Yan, and W. Jia 20S-Protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cell Planta Med 75 2009 1124 1128
7. C.H. Choi, G. Kang, and Y.D. Min Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korear red ginseng Planta Med 69 2003 235 240 (Pubitemid 36470128)
8. J. Jin, S. Shahi, H.K. Kang, H.W. Veen, and T.P. Fan Metabolites of ginsenosides as novel BCRP inhibitors Biochem Biophys Res Commun 345 2006 1308 1314 (Pubitemid 43817877)
9. Y. Tian, H. Guo, J. Han, and D. Guo Microbial transformation of 20(S)-protopanaxatriol by Mucor spinosus J Nat Prod 68 2005 678 680 (Pubitemid 40825274)
10. C.S. Park, M.H. Yoo, K.H. Noh, and D.K. Oh Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases Appl Microbiol Biotechnol 87 2010 9 19
11. 1 Asian J Trad Med 4 2009 19 25
12. 1 by a purified β-glucosidase from Fusarium moniliforme var. subglutinans. Biotechnol Lett DOI 10.1007/s10529-011-0719-0.
13. 1 Chem Pharm Bull 51 2003 404 408 (Pubitemid 41694814)
14. 1 by Fusarium oxysporum J Asian Nat Prod Res 13 2011 652 658
15. Huang W. Novel dammarane sapogenins and their use as anti-cancer agents. 2005; Pub. No. WO2005/040189.
16. T. Fujioka, Y. Iwase, H. Okabe, K. Mihashi, and T. Yamauchi Studies on the constituents of Actinostemma lobatum Maxim. II. Structures of actinostemmosides G and H, new dammarane triterpene glycosides isolated from the herb. Chem Pharm Bull 35 1987 3870 3873
17. Zhao X, Ph.D. Degree thesis, (2004) Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
18. L. Green, J. Reade, and C. Ware Rapid colormetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines J Immunol Methods 70 1984 257 268 (Pubitemid 14111307)